465 (Rizatriptan benzoate 5 mg (base))
This pill with imprint "465" is Brown, Round and has been identified as Rizatriptan benzoate 5 mg (base). It is manufactured by Glenmark Generics Inc., USA.
Rizatriptan is used in the treatment of migraine and belongs to the drug class antimigraine agents. Risk cannot be ruled out during pregnancy. Rizatriptan 5 mg (base) is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- 465
- Strength:
- 5 mg (base)
- Color:
- Brown
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Antimigraine agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Glenmark Generics Inc., USA
- National Drug Code (NDC):
- 68462-0465
- Inactive Ingredients:
- lactose monohydrate
microcrystalline cellulose
corn starch
ferric oxide red
magnesium stearate
silicon dioxide
Note: Inactive ingredients may vary.
More about rizatriptan
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 204 Reviews – Add your own review/rating
- Drug class: antimigraine agents
Consumer resources
Other brands: Maxalt, Maxalt-MLT
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
